Skip to content

Clinical trials

Alzheimer Disease trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Hong Kong Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20071
20091
20141
20163
20184
20192
20202
20211
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Terminated5
Unknown status2
Not yet recruiting1
Suspended1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong10
The University of Hong Kong4
The Hong Kong Polytechnic University3
GlaxoSmithKline2
Hoffmann-La Roche2
Pfizer2
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease25
Dementia8
Cognitive Dysfunction4
Brain Diseases3
Brain Ischemia2
Ischemic Stroke2
Neurocognitive Disorders2
Neurodegenerative Diseases2
Stroke2
Amyloid Neuropathies, Familial1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.